Holter ECG Market

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Holter ECG Market by Product (Wired Holter ECG, Wireless Holter ECG, Software), Lead Type (Patch Type 1-Lead, 3-Lead, 6-Lead, 12-Lead), EndUser (Hospitals and Specialty Clinics, Ambulatory Surgical Centers), & Region - Global Forecast to 2027

FREE BROCHURE FREE SAMPLE REPORT

Report Code: MD 8622 Apr, 2023, by marketsandmarkets.com

The global holter ECG market in terms of revenue was estimated to be worth $416 million in 2022 and is poised to reach $558 million by 2027, growing at a CAGR of 6.1% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The market is expanding due to factors including the rising prevalence of cardiovascular disease (CVD) patients and the requirement for early detection. The growing aging population and technological developments in wireless monitoring and wearable technology also support market growth. However, the lack of qualified professionals to accurately monitor Holter ECG results is projected to restrain the market.

Attractive Opportunities in the Holter ECG Market

Holter ECG Market

To know about the assumptions considered for the study, Request for Free Sample Report

Holter ECG Market

Holter ECG Market Dynamics

DRIVER: Increasing prevalence of cardiovascular disease

The demand for Holter ECG devices is increasing as these devices help save patients at high risk of cardiac arrest with early diagnosis and detection. Most types of CVD can be prevented through pre-monitoring and pre-diagnosis and thereby abnormalities in the functioning of the heart can be averted with early diagnosis.

Also, the rising prevalence of CVD is creating a requirement for cardiac care centers that are well-equipped with affordable and advanced Holter ECG devices to enable early and effective detection and treatment along with regular checkups; the demand is gradually rising in lower and middle-income countries in Latin America, the Asia Pacific, and the Middle East & Africa. These factors are expected to increase the demand for Holter ECG devices and, in turn, drive the market for Holter ECG in the coming years.

RESTRAINT: Frequent Product Recalls

The market witnesses a number of product recalls mainly due to reasons related to electrical failure, connector compatibility issues, and issues pertaining to specific defribillators. For example, Philips (Netherlands), recalled their Philips HeartStrart MRx Monitor due to therapy switch failure issue.

OPPORTUNITY: Untapped emerging markets

Developing countries across the world, including BRIC, are potential high-growth markets for Holter ECG monitors. China and India are home to more than one-third of the global population. Rapid urbanization, changing diets, sedentary lifestyles, and the rising use of tobacco and alcohol have increased the prevalence of CVD in these countries. Moreover, these countries have a high prevalence of hypertension, dyslipidemia, diabetes, and obesity, which are major risk factors for CVD.

Considering these factors, the demand for diagnostic Holter ECG devices is expected to increase in emerging markets in the coming years. Additionally, increasing awareness of cardiac disorders and personal care, increased per capita spending, and growing investments in emerging markets (considering the saturation in developed markets) are expected to offer potential growth opportunities to the manufacturers of Holter ECG monitors.

CHALLENGE: Stringent regulatory requirements delaying approval of cardiac devices

The presence of stringent regulatory policies has delayed the launch of various innovative products, which has hampered the growth of the market to a certain extent. Despite the growing demand for cardiac monitoring devices, including Holter ECG devices, manufacturers face several regulatory barriers due to regulations laid down by the FDA and other regulatory authorities around the world. Various regulatory authorities are increasingly enforcing complex laws governing the development and approval, manufacturing, labeling, market launch, commercialization, and sales of these devices. FDA guidelines require a mandatory post-marketing survey to further validate the efficacy and safety profile of cardiac monitoring and management devices, including Class II (pacemakers) and III (defibrillators) devices, after granting 510(k) clearance The FDA review of an application for PMA is supposed to take six months—twice as long as 510(k)—but may, and usually does, take longer.

Holter ECG Ecosystem

Prominent companies in this market include well-established, financially stable manufacturers of Holter ECG devices. These companies have been operating in the market for several years and possess a diversified product portfolio, state-of-the-art technologies, and strong global sales and marketing networks. Prominent companies in this market include GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), and Hill-Rom Holdings, Inc. (Baxter International Inc.) (US).

Holter ECG Market Ecosystem

By product segment, the wireless Holter ECG monitors to observe the highest market growth rate in holter ECG market

Based on the products, the global market is broadly segmented into wired Holter ECG monitors, wireless Holter ECG monitors, and software. Wireless Holter ECG monitors segment to observe the highest growth rate during the forecast period. The high growth rate is because they are comfortable to wear, are generally user-friendly, and do not need medical expertise.

12-lead Holter monitors segment to dominate the Holter ECG market, by lead type

Based on lead type, the market is segmented into patch type 1-lead, 3-lead, 6-lead, 12-lead, and other lead types (such as 4-, 5-, and 7-lead Holter ECG monitors, among others). 12-lead Holter monitor dominates the market due to the higher clarity obtained by using a larger number of leads; 12-lead ECG devices provide a highly detailed outlook, making it easier to interpret cardiac electrical activity.

Hospitals and specialty clinics segment to dominate the holter ECG market

Based on end user, the market is segmented into hospitals and specialty clinics, ambulatory surgical centers, and other end users (homecare settings, pharmaceutical companies, long-term care facilities, and academic and research institutes). Hospitals and specialty clinics dominate the market due to the growing number of patient visits to hospitals for the diagnosis of CVD and the increasing number of cardiac implant procedures and their early diagnosis.

North America to dominate in Holter ECG market

The global market is segmented into North America, Europe, Asia Pacific, Latin America and Middle-East Africa. North America is expected to dominate during the forecast period, primarily due increasing prevalence of cardiovascular disease, the growing aging population, and the rising demand for remote monitoring coupled with growing availability of various monitoring and therapeutics devices.

Holter ECG Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The Holter ECG market is dominated by players such as GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), Nihon Kohden Corporation (Japan), OSI Systems, Inc. (US), and Hill-Rom Holdings, Inc. (Baxter International Inc.) (US).

Holter ECG Market Report Scope:

Report Metric	Details
Market Revenue in 2022	$416 million
Projected Revenue by 2027	$558 million
Revenue Rate	poised to grow at a CAGR of 6.1%
Market Driver	Increasing prevalence of cardiovascular disease
Market Opportunity	Untapped emerging markets

This research report categorizes the Holter ECG market to forecast revenue and analyze trends in each of the following submarkets:

By Region

North America
Europe
Asia Pacific
Latin America
Middle-East Africa

By Product

Wired Holter ECG Monitors
Wireless Holter ECG Monitors
Software

By Lead Type

12-lead Holter Monitors
3-lead Holter Monitors
Patch Type 1-lead Holter Monitors
6-lead Holter Monitors
Other Lead Types

By End User

Hospitals and Specialty Clinics
Ambulatory Surgical Centers
Other End Users

Recent Developments:

In 2022, Royal Philips (Netherlands) partnered with Prisma Health (US) to help the health system achieve enterprise interoperability, standardize patient monitoring, and drive innovation in enterprise imaging solutions to enhance patient care and improve clinical performance.
In 2021, Royal Philips (Netherlands) acquired BioTelemetry, Inc. & Capsule Technologie (US) to strengthen Philips’ cardiac care portfolio, cardiac diagnostics, and monitoring services, which are included in the Connected Care segment.

Frequently Asked Questions (FAQ):

What is the projected market revenue value of the holter ECG market?

The holter ECG market boasts a total revenue value of $558 million by 2027.

What is the estimated growth rate (CAGR) of the holter ECG market?

The global holter ECG market has an estimated compound annual growth rate (CAGR) of 6.1% and a revenue size in the region of $416 million in 2022.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 25)

1.1 STUDY OBJECTIVES

1.2 MARKET DEFINITION

1.2.1 INCLUSIONS AND EXCLUSIONS

1.3 MARKETS COVERED

1.3.1 HOLTER ECG MARKET SEGMENTATION

1.3.2 GEOGRAPHIC SCOPE

1.3.3 YEARS CONSIDERED

1.4 CURRENCY CONSIDERED

1.5 STUDY LIMITATIONS

1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 29)

2.1 RESEARCH DATA

FIGURE 1 HOLTER ECG MARKET: RESEARCH DESIGN METHODOLOGY

2.1.1 SECONDARY DATA

2.1.1.1 Key data from secondary sources

2.1.2 PRIMARY DATA

2.1.2.1 Primary sources

2.1.2.2 Key data from primary sources

2.1.2.3 Key industry insights

2.1.2.4 Breakdown of primary interviews

FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS

FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION

2.2 MARKET SIZE ESTIMATION

2.2.1 BOTTOM-UP APPROACH

2.2.1.1 Approach 1: Company revenue estimation approach

FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH

2.2.1.2 Approach 2: Presentations of companies and primary interviews

2.2.1.3 Growth forecast

2.2.1.4 CAGR projections

FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS

2.2.2 TOP-DOWN APPROACH

FIGURE 6 MARKET: TOP-DOWN APPROACH

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION

FIGURE 7 DATA TRIANGULATION METHODOLOGY

2.4 MARKET SHARE

2.5 STUDY ASSUMPTIONS

2.6 RISK ASSESSMENT

2.6.1 RISK ASSESSMENT: MARKET

2.7 RECESSION IMPACT

3 EXECUTIVE SUMMARY (Page No. - 41)

FIGURE 8 HOLTER ECG MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)

FIGURE 9 MARKET, BY LEAD TYPE, 2022 VS. 2027 (USD MILLION)

FIGURE 10 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)

FIGURE 11 GEOGRAPHICAL SNAPSHOT OF MARKET, 2022 VS. 2027 (USD MILLION)

4 PREMIUM INSIGHTS (Page No. - 44)

4.1 HOLTER ECG MARKET OVERVIEW

FIGURE 12 RISING INCIDENCE OF CARDIOVASCULAR DISEASE TO DRIVE MARKET GROWTH

4.2 MARKET SHARE, BY PRODUCT, 2022 VS. 2027

FIGURE 13 WIRED HOLTER ECG MONITORS SEGMENT TO HOLD LARGEST SHARE OF MARKET IN 2027

4.3 MARKET SHARE, BY LEAD TYPE, 2022 VS. 2027

FIGURE 14 12-LEAD HOLTER MONITORS SEGMENT TO ACCOUNT FOR LARGEST MARKET SHARE IN 2027

4.4 MARKET SHARE, BY END USER, 2022 VS. 2027

FIGURE 15 HOSPITALS AND SPECIALTY CLINICS SEGMENT TO DOMINATE MARKET IN 2027

4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 47)

5.1 INTRODUCTION

5.2 MARKET DYNAMICS

FIGURE 17 HOLTER ECG MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES

5.2.1 DRIVERS

5.2.1.1 Rising geriatric population

FIGURE 18 GROWTH IN AGING POPULATION, BY COUNTRY, 2015 VS. 2030

5.2.1.2 Increasing prevalence of cardiovascular disease

5.2.1.3 Technological advancements in wireless monitoring and wearable devices

5.2.1.4 Increasing investments, funds, and grants for research on cardiac monitoring

5.2.2 RESTRAINTS

5.2.2.1 Frequent product recalls

TABLE 1 KEY PRODUCT RECALLS

5.2.3 OPPORTUNITIES

5.2.3.1 Untapped emerging markets

5.2.4 CHALLENGES

5.2.4.1 Stringent regulatory requirements delaying approval of cardiac devices

5.2.4.2 Dearth of skilled professionals with expertise in handling cardiac monitoring devices

5.3 PRICING ANALYSIS

TABLE 2 AVERAGE SELLING PRICE OF HOLTER ECG MONITORING PRODUCTS (2022)

5.4 PATENT ANALYSIS

FIGURE 19 PATENT ANALYSIS FOR MARKET

5.4.1 LIST OF KEY PATENTS

5.5 VALUE CHAIN ANALYSIS

FIGURE 20 VALUE CHAIN ANALYSIS OF MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES

5.6 SUPPLY CHAIN ANALYSIS

FIGURE 21 MARKET: SUPPLY CHAIN ANALYSIS

5.7 ECOSYSTEM ANALYSIS

FIGURE 22 MARKET: ECOSYSTEM ANALYSIS

5.7.1 MARKET: ROLE IN ECOSYSTEM

5.8 PORTER’S FIVE FORCES ANALYSIS

TABLE 3 MARKET: PORTER’S FIVE FORCES ANALYSIS

5.8.1 THREAT OF NEW ENTRANTS

5.8.2 THREAT OF SUBSTITUTES

5.8.3 BARGAINING POWER OF BUYERS

5.8.4 BARGAINING POWER OF SUPPLIERS

5.8.5 INTENSITY OF COMPETITIVE RIVALRY

5.9 REGULATORY ANALYSIS

TABLE 4 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 5 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 6 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 7 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

TABLE 8 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

5.9.1 NORTH AMERICA

5.9.1.1 US

5.9.1.2 Canada

5.9.2 EUROPE

5.9.3 ASIA PACIFIC

5.9.3.1 China

5.9.3.2 Japan

5.9.3.3 India

5.9.4 LATIN AMERICA

5.9.4.1 Brazil

5.9.4.2 Mexico

5.9.5 MIDDLE EAST

5.9.6 AFRICA

5.10 TRADE ANALYSIS

5.10.1 TRADE ANALYSIS FOR HOLTER ECG PRODUCTS

TABLE 9 IMPORT DATA FOR HOLTER ECG PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)

TABLE 10 EXPORT DATA FOR HOLTER ECG PRODUCTS, BY COUNTRY, 2018–2022 (USD MILLION)

5.11 PESTLE ANALYSIS

5.12 TECHNOLOGY ANALYSIS

5.13 KEY CONFERENCES AND EVENTS, 2023–2024

TABLE 11 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS

5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES

5.14.1 REVENUE SHIFT AND REVENUE POCKETS FOR HOLTER ECG MONITOR MANUFACTURERS

FIGURE 23 REVENUE SHIFT IN MARKET

5.15 KEY STAKEHOLDERS AND BUYING CRITERIA

5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS

FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOLTER ECG PRODUCTS

TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HOLTER ECG PRODUCTS

5.15.2 BUYING CRITERIA

FIGURE 25 KEY BUYING CRITERIA FOR HOLTER ECG PRODUCTS

TABLE 13 KEY BUYING CRITERIA FOR HOLTER ECG PRODUCTS

5.16 CASE STUDIES

5.16.1 CASE STUDY 1

5.16.2 CASE STUDY 2

6 HOLTER ECG MARKET, BY PRODUCT (Page No. - 72)

6.1 INTRODUCTION

TABLE 14 MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

6.2 WIRED HOLTER ECG MONITORS

6.2.1 GROWING CVD PREVALENCE AND NEED FOR CONTINUOUS MONITORING TO FUEL GROWTH

TABLE 15 INDICATIVE LIST OF WIRED HOLTER ECG MONITORS

TABLE 16 WIRED HOLTER ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)

6.3 WIRELESS HOLTER ECG MONITORS

6.3.1 INCREASING PREFERENCE FOR COMFORTABLE CARDIAC ACTIVITY MONITORING TO DRIVE GROWTH

TABLE 17 INDICATIVE LIST OF WIRELESS HOLTER ECG MONITORS

TABLE 18 WIRELESS HOLTER ECG MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)

6.4 SOFTWARE

6.4.1 HOLTER ECG SOFTWARE HELPS PROVIDE CLINICIANS WITH QUICK INSIGHTS AND PROTECTED PATIENT DATA

TABLE 19 HOLTER ECG SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)

7 HOLTER ECG MARKET, BY LEAD TYPE (Page No. - 77)

7.1 INTRODUCTION

TABLE 20 MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

7.2 PATCH TYPE 1-LEAD HOLTER MONITORS

7.2.1 EASE OF USE FOR DIAGNOSIS AND QUICK RESULTS TO PROPEL MARKET GROWTH

TABLE 21 PATCH TYPE 1-LEAD HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)

7.3 3-LEAD HOLTER MONITORS

7.3.1 3-LEAD HOLTER MONITORS PERFORM MULTIPLE DIAGNOSTIC TESTS SIMULTANEOUSLY

TABLE 22 KEY PRODUCTS IN 3-LEAD HOLTER MONITORS MARKET

TABLE 23 3-LEAD HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)

7.4 6-LEAD HOLTER MONITORS

7.4.1 WIDE USE OF 6-LEAD HOLTER MONITORS FOR REMOTE PATIENT MONITORING TO DRIVE GROWTH

TABLE 24 KEY PRODUCTS IN 6-LEAD HOLTER MONITORS MARKET

TABLE 25 6-LEAD HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)

7.5 12-LEAD HOLTER MONITORS

7.5.1 WIDE USE IN PRE-HOSPITAL AND CLINIC SETTINGS TO DRIVE GROWTH

TABLE 26 KEY PRODUCTS IN 12-LEAD HOLTER MONITORS MARKET

TABLE 27 12-LEAD HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)

7.6 OTHER LEAD TYPES

TABLE 28 OTHER LEAD TYPE HOLTER MONITORS MARKET, BY REGION, 2020–2027 (USD MILLION)

8 HOLTER ECG MARKET, BY END USER (Page No. - 83)

8.1 INTRODUCTION

TABLE 29 MARKET, BY END USER, 2020–2027 (USD MILLION)

8.2 HOSPITALS AND SPECIALTY CLINICS

8.2.1 INCREASING NUMBER OF CARDIAC CENTERS TO SUPPORT GROWTH

TABLE 30 MARKET FOR HOSPITALS AND SPECIALTY CLINICS, BY REGION, 2020–2027 (USD MILLION)

8.3 AMBULATORY SURGICAL CENTERS

8.3.1 LOW-COST PROCEDURES TO DRIVE MARKET GROWTH

TABLE 31 MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020–2027 (USD MILLION)

8.4 OTHER END USERS

TABLE 32 MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)

9 HOLTER ECG MARKET, BY REGION (Page No. - 88)

9.1 INTRODUCTION

TABLE 33 MARKET, BY REGION, 2020–2027 (USD MILLION)

9.2 NORTH AMERICA

FIGURE 26 NORTH AMERICA: HOLTER ECG MARKET SNAPSHOT

TABLE 34 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

TABLE 35 NORTH AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 36 NORTH AMERICA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 37 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.2.1 RECESSION IMPACT

9.2.2 US

9.2.2.1 Rising prevalence of heart diseases to drive growth

TABLE 38 US: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 39 US: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 40 US: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.2.3 CANADA

9.2.3.1 Increasing geriatric patient pool to support growth

TABLE 41 CANADA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 42 CANADA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 43 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.3 EUROPE

TABLE 44 EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP)

TABLE 45 EUROPE: HOLTER ECG MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

TABLE 46 EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 47 EUROPE: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 48 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.3.1 RECESSION IMPACT

9.3.2 GERMANY

9.3.2.1 Increasing healthcare expenditure to fuel market growth

TABLE 49 GERMANY: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 50 GERMANY: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 51 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.3.3 UK

9.3.3.1 Rising demand for home-based cardiac monitoring devices to support market growth

TABLE 52 UK: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 53 UK: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 54 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.3.4 FRANCE

9.3.4.1 Increasing risk of cardiovascular disease to propel growth

TABLE 55 FRANCE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 56 FRANCE: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 57 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.3.5 ITALY

9.3.5.1 High prevalence of cardiovascular disease to drive growth

TABLE 58 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (THOUSAND)

TABLE 59 ITALY: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 60 ITALY: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 61 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.3.5.2 Rising geriatric population to propel growth

TABLE 62 SPAIN: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 63 SPAIN: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 64 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.3.6 NETHERLANDS

9.3.6.1 Increasing prevalence of coronary heart disease to drive growth

TABLE 65 NETHERLANDS: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 66 NETHERLANDS: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 67 NETHERLANDS: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.3.7 REST OF EUROPE

TABLE 68 PERCENTAGE OF POPULATION AGED 60 OR OVER, 2017 VS. 2050

TABLE 69 REST OF EUROPE: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 70 REST OF EUROPE: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 71 REST OF EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4 ASIA PACIFIC

FIGURE 27 ASIA PACIFIC: HOLTER ECG MARKET SNAPSHOT

TABLE 72 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

TABLE 73 ASIA PACIFIC: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 74 ASIA PACIFIC: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 75 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4.1 RECESSION IMPACT

9.4.2 CHINA

9.4.2.1 Growing public access to modern healthcare to support growth

TABLE 76 CHINA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 77 CHINA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 78 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4.3 JAPAN

9.4.3.1 Favorable regulatory framework to drive growth

TABLE 79 JAPAN: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 80 JAPAN: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 81 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4.4 INDIA

9.4.4.1 Increasing investment in healthcare system to drive market

TABLE 82 INDIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 83 INDIA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 84 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4.5 AUSTRALIA

9.4.5.1 Initiatives to enhance healthcare access and infrastructure to drive market

TABLE 85 AUSTRALIA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 86 AUSTRALIA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 87 AUSTRALIA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4.6 THAILAND

9.4.6.1 Increasing healthcare expenditure to drive growth

TABLE 88 THAILAND: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 89 THAILAND: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 90 THAILAND: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4.7 SINGAPORE

9.4.7.1 Increasing demand for health and aged care services to drive market

TABLE 91 SINGAPORE: PERCENTAGE OF DEATHS FROM CARDIOVASCULAR DISEASE

TABLE 92 SINGAPORE: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 93 SINGAPORE: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 94 SINGAPORE: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4.8 INDONESIA

9.4.8.1 Rising number of CVD cases to drive growth

TABLE 95 INDONESIA: NUMBER OF ELDERLY CITIZENS (THOUSAND)

TABLE 96 INDONESIA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 97 INDONESIA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 98 INDONESIA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.4.9 REST OF ASIA PACIFIC

TABLE 99 REST OF ASIA PACIFIC: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 100 REST OF ASIA PACIFIC: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 101 REST OF ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.5 LATIN AMERICA

TABLE 102 LATIN AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)

TABLE 103 LATIN AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 104 LATIN AMERICA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 105 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.5.1 RECESSION IMPACT

9.5.2 BRAZIL

9.5.2.1 Increasing prevalence of CVD to drive growth

TABLE 106 BRAZIL: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 107 BRAZIL: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 108 BRAZIL: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.5.3 REST OF LATIN AMERICA

TABLE 109 REST OF LATIN AMERICA: MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 110 REST OF LATIN AMERICA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 111 REST OF LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.6 MIDDLE EAST & AFRICA

TABLE 112 MIDDLE EAST & AFRICA: HOLTER ECG MARKET, BY PRODUCT, 2020–2027 (USD MILLION)

TABLE 113 MIDDLE EAST & AFRICA: MARKET, BY LEAD TYPE, 2020–2027 (USD MILLION)

TABLE 114 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)

9.6.1 RECESSION IMPACT

10 COMPETITIVE LANDSCAPE (Page No. - 136)

10.1 OVERVIEW

10.2 STRATEGIES OF KEY PLAYERS

10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HOLTER ECG MARKET

TABLE 115 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS

10.3 REVENUE SHARE ANALYSIS

FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN MARKET

10.4 MARKET SHARE ANALYSIS

FIGURE 29 MARKET SHARE, BY KEY PLAYER (2021)

TABLE 116 MARKET SHARE: DEGREE OF COMPETITION

10.5 COMPETITIVE LEADERSHIP MAPPING

10.5.1 LIST OF EVALUATED VENDORS

10.5.2 STARS

10.5.3 EMERGING LEADERS

10.5.4 PERVASIVE PLAYERS

10.5.5 PARTICIPANTS

FIGURE 30 MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021

10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES

10.6.1 PROGRESSIVE COMPANIES

10.6.2 STARTING BLOCKS

10.6.3 RESPONSIVE COMPANIES

10.6.4 DYNAMIC COMPANIES

FIGURE 31 MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021

10.7 COMPETITIVE BENCHMARKING

10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS

FIGURE 32 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS

TABLE 117 MARKET: REGIONAL FOOTPRINT OF TOP PLAYERS

TABLE 118 MARKET: PRODUCT FOOTPRINT OF TOP PLAYERS

TABLE 119 HOLTER ECG MARKET: DETAILED LIST OF KEY START-UPS/SMES

10.8 COMPETITIVE SCENARIO

10.8.1 PRODUCT LAUNCHES AND APPROVALS

TABLE 120 KEY PRODUCT LAUNCHES AND APPROVALS

10.8.2 DEALS

TABLE 121 KEY DEALS

11 COMPANY PROFILES (Page No. - 147)

11.1 KEY PLAYERS

(Business Overview, Products Offered, Recent Developments, and MnM View)*

11.1.1 GE HEALTHCARE

TABLE 122 GE HEALTHCARE: BUSINESS OVERVIEW

FIGURE 33 GE HEALTHCARE: COMPANY SNAPSHOT (2021)

11.1.2 KONINKLIJKE PHILIPS N.V.

TABLE 123 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW

FIGURE 34 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)

11.1.3 NIHON KOHDEN CORPORATION

TABLE 124 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW

FIGURE 35 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2021)

11.1.4 OSI SYSTEMS, INC.

TABLE 125 OSI SYSTEMS, INC: BUSINESS OVERVIEW

FIGURE 36 OSI SYSTEMS, INC.: COMPANY SNAPSHOT (2021)

11.1.5 HILL-ROM HOLDINGS, INC. (BAXTER INTERNATIONAL INC.)

TABLE 126 HILL-ROM HOLDINGS, INC.: BUSINESS OVERVIEW

FIGURE 37 HILL-ROM HOLDINGS, INC.: COMPANY SNAPSHOT (2021)

11.1.6 MINDRAY MEDICAL INTERNATIONAL LIMITED

TABLE 127 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW

FIGURE 38 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2021)

11.1.7 SCHILLER AG

TABLE 128 SCHILLER AG: BUSINESS OVERVIEW

11.1.8 BITTIUM CORPORATION

TABLE 129 BITTIUM CORPORATION: BUSINESS OVERVIEW

FIGURE 39 BITTIUM CORPORATION: COMPANY SNAPSHOT (2021)

11.1.9 FUKUDA DENSHI CO., LTD.

TABLE 130 FUKUDA DENSHI CO., LTD.: BUSINESS OVERVIEW

FIGURE 40 FUKUDA DENSHI CO., LTD.: COMPANY SNAPSHOT (2021)

11.1.10 BPL MEDICAL TECHNOLOGIES PVT. LTD.

TABLE 131 BPL MEDICAL TECHNOLOGIES PVT. LTD.: BUSINESS OVERVIEW

* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.

11.2 OTHER PLAYERS

11.2.1 MEDITECH EQUIPMENT CO. LTD.

11.2.2 MIDMARK CORPORATION

11.2.3 ALIVECOR, INC.

11.2.4 VITALCONNECT

11.2.5 IRHYTHM TECHNOLOGIES, INC.

11.2.6 BORSAM BIOMEDICAL INSTRUMENTS CO., LTD.

11.2.7 NASIFF ASSOCIATES, INC.

11.2.8 NASAN MEDICAL ELECTRONICS PVT. LTD.

11.2.9 VECTRACOR

11.2.10 SCOTTCARE CORPORATION

11.2.11 BIOMEDICAL INSTRUMENTS CO. LTD.

11.2.12 EB NEURO S.P.A.

11.2.13 VIATOM TECHNOLOGY CO., LTD.

11.2.14 CARDIAC INSIGHT, INC.

11.2.15 LIFESIGNALS, INC.

12 APPENDIX (Page No. - 180)

12.1 DISCUSSION GUIDE

12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

12.3 CUSTOMIZATION OPTIONS

12.4 RELATED REPORTS

12.5 AUTHOR DETAILS

The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, challenges, restraints, and key player strategies. To track company developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships of the leading players, the competitive landscape of the Holter ECG market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Collecting Secondary Data

The secondary research data collection process involves the usage of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), annual reports, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Holter ECG market. A database of the key industry leaders was also prepared using secondary research.

Collecting Primary Data

The primary research data was conducted after acquiring knowledge about the Holter ECG market scenario through secondary research. A significant number of primary interviews were conducted with stakeholders from both the demand side (such as research laboratories, hospitals, research institutes, diagnostic laboratories, and pharmaceutical companies) and supply side (such as included various industry experts, such as Directors, Chief X Officers (CXOs), Vice Presidents (VPs) from business development, marketing, and product development teams, product manufacturers, wholesalers, channel partners, and distributors) across major countries of North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America. Approximately 40% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 60%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Breakdown of Primary Participants:

Holter ECG Market Size, and Share

Note 1: *Others include sales managers, marketing managers, and product managers.

Note 2: Tiers are defined based on a company’s total revenue as of 2022: Tier 1=> USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3=< USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

All major product manufacturers offering various Holter ECG devices were identified at the global/regional level. Revenue mapping was done for the major players and was extrapolated to arrive at the global market value of each type of segment. The market value Holter ECG market was also split into various segments and subsegments at the region and country level based on:

Product mapping of various manufacturers for each type of Holter ECG market at the regional and country-level
Relative adoption pattern of each Holter ECG market among key application segments at the regional and/or country-level
Detailed primary research to gather qualitative and quantitative information related to segments and subsegments at the regional and/or country-level.
Detailed secondary research to gauge the prevailing market trends at the regional and/or country-level

Market Size: Top Down Approach

Holter ECG Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Data Triangulation

After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Holter ECG industry.

Market Definition

Holter ECG, also known as a continuous monitor, is a small and sophisticated ambulatory monitor used to record the heart’s electrical activity continuously for 24–48 hours. Its extended recording period is useful for observing occasional cardiac arrhythmias, which would be difficult to identify in a shorter period.

Key Stakeholders

Senior Management
Finance/Procurement Department
Hospitals and clinics

Report Objectives

To provide detailed information about the factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To define, describe, segment, and forecast the Holter ECG market by product, lead type, end user, and region
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall Holter ECG market
To forecast the size of the Holter ECG market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and Middle-East Africa.
To profile key players in the Holter ECG market and comprehensively analyze their core competencies and market shares
To track and analyze competitive developments, such as acquisitions; product launches; expansions; collaborations, agreements, & partnerships; and R&D activities of the leading players in the Holter ECG market
To benchmark players within the Holter ECG market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

Additional country-level analysis of the Holter ECG market
Profiling of additional market players (up to 5)

Product Analysis

Product matrix, which provides a detailed comparison of the product portfolio of each company in the Holter ECG Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.